John Francis Sedgwick

Dr. John Francis Sedgwick

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2012 in Journal of the American Society of Echocardiography
Verified
Journal Article
Closed access
DPDavid Platts
David Platts
JSJohn Francis Sedgwick
John Francis Sedgwick
DBDarryl John Burstow
Darryl John Burstow
DMDaniel Vincent Mullany
Daniel Vincent Mullany
JFJohn Francis Fraser
John Francis Fraser

29 April 2012 in Current Infectious Disease Reports
Verified
Journal Article
Closed access
PDF file
JSJohn Francis Sedgwick
John Francis Sedgwick
DBDarryl John Burstow
Darryl John Burstow

31 March 2011 in International Journal of Cardiology
Verified
Journal Article
Closed access
JSJohn Francis Sedgwick
John Francis Sedgwick
DBD.J. Burstow
D.J. Burstow
DPD.G. Platts
D.G. Platts

19 February 2019 in Australasian Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
PDF file
MVManan Vaishnav
Manan Vaishnav
JSJohn Francis Sedgwick
John Francis Sedgwick

1 December 2017 in IJC Heart & Vasculature
Verified
Journal Article
Open access
DPDavid Platts
David Platts
MVManan Vaishnav
Manan Vaishnav
DBDarryl J. Burstow
Darryl J. Burstow
Christian Hamilton-CraigChristian Hamilton-Craig
Christian Hamilton-Craig
JCJonathan Chan
Jonathan Chan
GSGregory M. Scalia
Gregory M. Scalia
Accurate evaluation of the tricuspid regurgitant (TR) spectral Doppler signal is important during transthoracic echocardiographic (TTE) evaluation for pulmonary hypertension (PHT). Contrast enhancement improves Doppler backscatter. However, its incremental benefit with contemporary scanners is less well established. The aim of this study was to assess whether the TR spectral Doppler signal using contemporary scanners was improved using a second generation contrast agent, Definity® (CE), compared to unenhanced TTE (UE). Analysis of patients who underwent UE then CE TR interrogation was performed. TR signal was evaluated by an experienced reader and graded 1 (clear-high level of confidence of interpretation and complete spectral Doppler envelope), 2 (suboptimal with medium-low level of confidence of interpretation and incomplete envelope), 3 (poor-absent and no measurable spectral Doppler signal). Maximal TR velocity (TRV) was defined as peak velocity that could be clearly identified. An inexperienced sonographer read 30 randomly selected studies. 176 TTE were performed in 173 patients (mean age 57 ± 14.8 years). Wilcoxon signed rank test demonstrated significant improvement (p < 0.0001) in TR spectral Doppler signal quality with CE TTE. Mean score CE TTE vs. TTE = 2.32 ± 0.85 vs. 2.56 ± 0.75 respectively (p < 0.0001). Mean maximal TRV CE TTE vs. UE TTE = 2.61 ± 0.44 m/s vs. 2.54 ± 0.49 m/s respectively (p < 0.0001). The inexperienced reader had a greater improvement in scoring CE TTE signals vs. UE TTE (p < 0.0001). In the era of contemporary scanners, CE improved the ability to detect and measure TRV, except in those with clear unenhanced TR spectral Doppler signals or greater than mild tricuspid regurgitation.

1 December 2015 in International Journal of Cardiology
Verified
Journal Article
Closed access
TBThomas Butler
Thomas Butler
CTCatherina Tjahjadi
Catherina Tjahjadi
DKDong Kang
Dong Kang
DBDarryl J. Burstow
Darryl J. Burstow
JSJohn Francis Sedgwick
John Francis Sedgwick